Pharmacokinetics, protein binding, and extravascular distribution of ceftizoxime in normal subjects

L. R. Peterson, D. N. Gerding, L. L. van Etta, J. H. Eckfeldt, T. A. Larson

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Thirteen normal subjects were given 2, 3, or 4 g of ceftizoxime intravenously in a prospective single-blinded study. Serum and urine concentrations were measured for 48 h. The β-phase serum half-life ranged from 1.4 to 1.7 h. Approximately 100% of the agent was recovered unchanged in the urine over 48 h. Six of 13 subjects reported subjective complaints consisting of mild dizziness and moderate headache, all of which were transient. One subject also had a minimally elevated serum glutamic oxalacetic transaminase level 1 day after drug administration. Based on serum pharmacokinetics and serum protein binding determined in this investigation, unbound ceftizoxime appeared to distribute with the total body water.

Original languageEnglish (US)
Pages (from-to)878-881
Number of pages4
JournalUnknown Journal
Volume22
Issue number5
DOIs
StatePublished - Jan 1 1982

Fingerprint

Ceftizoxime
Pharmacokinetics
Protein Binding
Serum
Water
Urine
Body Water
Dizziness
Transaminases
Headache
Half-Life
Blood Proteins
Pharmaceutical Preparations

Cite this

Pharmacokinetics, protein binding, and extravascular distribution of ceftizoxime in normal subjects. / Peterson, L. R.; Gerding, D. N.; van Etta, L. L.; Eckfeldt, J. H.; Larson, T. A.

In: Unknown Journal, Vol. 22, No. 5, 01.01.1982, p. 878-881.

Research output: Contribution to journalArticle

Peterson, L. R. ; Gerding, D. N. ; van Etta, L. L. ; Eckfeldt, J. H. ; Larson, T. A. / Pharmacokinetics, protein binding, and extravascular distribution of ceftizoxime in normal subjects. In: Unknown Journal. 1982 ; Vol. 22, No. 5. pp. 878-881.
@article{c7491b8926fd445db6b0590f51e3a2e1,
title = "Pharmacokinetics, protein binding, and extravascular distribution of ceftizoxime in normal subjects",
abstract = "Thirteen normal subjects were given 2, 3, or 4 g of ceftizoxime intravenously in a prospective single-blinded study. Serum and urine concentrations were measured for 48 h. The β-phase serum half-life ranged from 1.4 to 1.7 h. Approximately 100{\%} of the agent was recovered unchanged in the urine over 48 h. Six of 13 subjects reported subjective complaints consisting of mild dizziness and moderate headache, all of which were transient. One subject also had a minimally elevated serum glutamic oxalacetic transaminase level 1 day after drug administration. Based on serum pharmacokinetics and serum protein binding determined in this investigation, unbound ceftizoxime appeared to distribute with the total body water.",
author = "Peterson, {L. R.} and Gerding, {D. N.} and {van Etta}, {L. L.} and Eckfeldt, {J. H.} and Larson, {T. A.}",
year = "1982",
month = "1",
day = "1",
doi = "10.1128/AAC.22.5.878",
language = "English (US)",
volume = "22",
pages = "878--881",
journal = "Journal of Fluid Mechanics",
issn = "0022-1120",
publisher = "Cambridge University Press",
number = "5",

}

TY - JOUR

T1 - Pharmacokinetics, protein binding, and extravascular distribution of ceftizoxime in normal subjects

AU - Peterson, L. R.

AU - Gerding, D. N.

AU - van Etta, L. L.

AU - Eckfeldt, J. H.

AU - Larson, T. A.

PY - 1982/1/1

Y1 - 1982/1/1

N2 - Thirteen normal subjects were given 2, 3, or 4 g of ceftizoxime intravenously in a prospective single-blinded study. Serum and urine concentrations were measured for 48 h. The β-phase serum half-life ranged from 1.4 to 1.7 h. Approximately 100% of the agent was recovered unchanged in the urine over 48 h. Six of 13 subjects reported subjective complaints consisting of mild dizziness and moderate headache, all of which were transient. One subject also had a minimally elevated serum glutamic oxalacetic transaminase level 1 day after drug administration. Based on serum pharmacokinetics and serum protein binding determined in this investigation, unbound ceftizoxime appeared to distribute with the total body water.

AB - Thirteen normal subjects were given 2, 3, or 4 g of ceftizoxime intravenously in a prospective single-blinded study. Serum and urine concentrations were measured for 48 h. The β-phase serum half-life ranged from 1.4 to 1.7 h. Approximately 100% of the agent was recovered unchanged in the urine over 48 h. Six of 13 subjects reported subjective complaints consisting of mild dizziness and moderate headache, all of which were transient. One subject also had a minimally elevated serum glutamic oxalacetic transaminase level 1 day after drug administration. Based on serum pharmacokinetics and serum protein binding determined in this investigation, unbound ceftizoxime appeared to distribute with the total body water.

UR - http://www.scopus.com/inward/record.url?scp=0020364644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020364644&partnerID=8YFLogxK

U2 - 10.1128/AAC.22.5.878

DO - 10.1128/AAC.22.5.878

M3 - Article

C2 - 6295270

AN - SCOPUS:0020364644

VL - 22

SP - 878

EP - 881

JO - Journal of Fluid Mechanics

JF - Journal of Fluid Mechanics

SN - 0022-1120

IS - 5

ER -